Granulocyte Colony-stimulating Factor-induced Aortitis with Lung Injury, Splenomegaly, and a Rash During Treatment for Recurrent Extraosseous Mucinous Chondrosarcoma-Reference-Cited by-同舟云学术

Granulocyte Colony-stimulating Factor-induced Aortitis with Lung Injury, Splenomegaly, and a Rash During Treatment for Recurrent Extraosseous Mucinous Chondrosarcoma

Published:2021-04-15 Issue:8 Volume:60 Page:1311-1315
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kametani Takahiro¹,Otani Yuichiro¹,Ohigashi Toshikazu²,Kubo Tadahiko³,Sakuda Tomohiko³,Furuta Daisuke³,Ito Yayoiko¹,Shigenobu Yuya¹,Kakimoto Masaki¹,Kawahara Akihiro¹,Kikuchi Yuka¹,Kobayashi Tomoki¹,Miyamori Daisuke¹,Kishikawa Nobusuke¹,Kanno Keishi¹,Ito Masanori¹

Affiliation:

1. Department of General Internal Medicine, Hiroshima University Hospital, Japan

2. Department of Pharmaceutical Services, Hiroshima University Hospital, Japan

3. Department of Orthopaedic Surgery, Hiroshima University, Graduate School of Biomedical & Health Sciences, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/8/60_5913-20/_pdf

Reference24 articles.

1. 1. Kuderer NM, Dale DC, Crawford J, et al. Impact of primary prophylaxis with granulocyte colony- stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 25: 3158-3167, 2007.

2. 2. Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325: 164-170, 1991.

3. 3. Lyman GH, Dale DC, ulakova EC, et al. The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol 24: 2475-2484, 2013.

4. 4. Teshima T, Takigawa N, Makita Y, et al. Results of a drug use survey of filgrastim biosimilar. Jpn J Cancer Chemother 44: 775-782, 2017.

5. 5. Masood N, Shaikh AJ, Memon WA, et al. Splenic rupture, secondary to G-CSF use for chemotherapy induced neutropenia: a case report and review of literature. Cases J 1: 418, 2008.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Aortitis after Administration of G-CSF during Neoadjuvant Chemotherapy for Breast Cancer;Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association);2023

2. A Case of Pegfilgrastim-induced Aortitis during Neoadjuvant Chemotherapy for Esophageal Cancer;Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association);2023

3. Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literature;Surgical Case Reports;2022-08-12

4. Aortitis and aortic dissection after administration of pegfilgrastim during adjuvant chemotherapy for early breast cancer;International Cancer Conference Journal;2022-02-23

5. Granulocyte colony stimulating factor (G-CSF)-induced aortitis in a patient undergoing adjuvant chemotherapy for breast cancer;BMJ Case Reports;2022-01